# Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

> **NCT03969693** · — · NOT_YET_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Mediastinal Lymphoma
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma

## Interventions

- **RADIATION:** Standard treatment protocol with combined chemoradiation

## Key facts

- **NCT ID:** NCT03969693
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969693, "Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03969693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*